CPX-351 (VYXEOS)
A Prospective, Single Site, Single-Arm Pilot Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 25 patients (estimated)
- Sponsors
- St. Jude Children's Research Center
- Collaborators
- Jazz Pharmaceuticals
- Tags
- Allogeneic Stem Cell Transplant, Chemotherapy, Steroid
- Trial Type
- Treatment
- Last Update
- 2 weeks ago
- SparkCures ID
- 1670
- NCT Identifier
- NCT05656248
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.